[ad_1]
Several studies have recently suggested that the vaccine against the tuberculosis – BCG – reduces the risk of contamination to SARS-CoV-2. A team of international researchers now states this the ROR vaccine (measles-mumps-rubella) can protect against COVID-19, or at least reduce the severity from symptoms. ” We found an inverse correlation between the levels ofantibody IgG mumps and the severity of Covid-19 in people under 42 vaccinated with MMR Says lead author of the study, Jeffrey E. Gold, president of the World Organization, in Watkinsville, Georgia. In other words, the higher the level of antibodies, the fewer subjects they have severe forms of Covid.
” This may explain why there are fewer cases and mortality much lower in children »(Most of them receive the first ROR vaccine from about 12 to 15 months and a second from about 4 to 6 years), attests the study published in mBio. The prevalence Covid-19 is therefore seven times lower in young children. On the other hand, no significant correlation with the antibodies of measles or rubella.
” The MMR II vaccine is considered to be a safe vaccine with very few side effects. If it has the advantage of preventing Covid-19 infection, preventing its spread or reducing its severity, or a combination of all of these, it is a high-level intervention. return for low risk », Jeffrey E. Gold attests. The authors therefore recommend the vaccination people over 40, often unprotected against mumps.
.
[ad_2]
Source link
